Anderson BT

Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, CA, United States; UC Berkeley Center for the Science of Psychedelics, Berkeley, CA, United States.

Anderson BT

Trends in first-time psychedelic and other hallucinogen use in the United States: Results from the National Survey on Drug Use and Health.

Investigating Safety Concerns and Harm Reduction in Entheogenic Churches: The Case for Community-Based Participatory Research.

Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.

Meaning and Psychedelics in Palliative Care: A Narrative Review.

US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022.

Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks.

Latent Classes of Lifetime Use of Seven Hallucinogens in the United States.

A systematic review of income and education reporting in psychedelic clinical trials.

On Minimizing Risk and Harm in the Use of Psychedelics.

Psychedelic Regulation Beyond the Controlled Substances Act: A Three-Dimensional Framework for Characterizing Policy Options.

Psilocybin-assisted therapy and HIV-related shame.

Older adults in psychedelic-assisted therapy trials: A systematic review.

Psychedelics in Addiction Treatment-Navigating a Sociopolitical Rift.

Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted Therapy.

Psychedelic therapies reconsidered: compounds, clinical indications, and cautious optimism.

Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.

Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.

If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.

Psychedelic medicine: safety and ethical concerns.

Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.

Psychedelic-Assisted Group Therapy: A Systematic Review.